Key result
Smoking predicts ~351% higher odds of VASP-P and LTA discordance for post-STEMI platelet reactivity.
Why the study?
Discordance between platelet VASP phosphorylation and light transmission aggregometry in defining high on-clopidogrel platelet reactivity after STEMI may be influenced by clinical characteristics and requires investigation.
What clinical characteristics predict discordance between VASP-P and LTA assays in defining high on-clopidogrel platelet reactivity in STEMI patients after primary PCI?
Observational (n=90)
What clinical characteristics predict discordance between VASP-P and LTA assays in defining high on-clopidogrel platelet reactivity in STEMI patients after primary PCI?
Answers are grounded in this paper and cite their sources.
Smoking and prolonged onset-to-admission time predict discordance between VASP-P and LTA assays for measuring clopidogrel responsiveness in STEMI patients, which may impact personalized antiplatelet therapy.
To investigate potential clinical characteristics associated with discordance between platelet vasodilator-stimulated phosphoprotein phosphorylation (VASP-P) flow cytometry (FCM) assay and light transmission aggregometry (LTA) in defining high on-clopidogrel platelet reactivity (HPR) after ST-segment elevation myocardial infarction (STEMI). In this study, platelet responsiveness was measured by the above 2 methods simultaneously on day 1 and on day 6 of STEMI onset in 90 consecutive patients who underwent primary percutaneous coronary intervention. The FCM-derived platelet reactivity index and LTA-derived platelet aggregation rate were both significantly reduced after dual antiplatelet therapy on day 6. Multiple variable-adjusted logistic regression analysis revealed that smoking (odds ratio [OR]: 4.507, 95% confidence interval [CI]: 1.123-18.09, P = .034) and onset-to-admission time (per 1 hour increase, OR: 1.196, 95% CI: 1.023-1.398, P = .025) both were independent predictors for the discordance between the 2 methods. Additionally, improved correlation and concordance was observed in nonsmokers compared with smokers. Our data show that smoking and prolonged onset-to-admission time are associated with discordance between platelet VASP-P and LTA in defining HPR after STEMI, which should be considered when planning personalized antiplatelet therapy.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2017) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=90). Smoking vs. Nonsmokers was evaluated on Discordance between VASP-P flow cytometry and LTA in defining high on-clopidogrel platelet reactivity (OR 4.507, 95% CI 1.123-18.09, p=.034). Smoking and prolonged onset-to-admission time independently predicted discordance between VASP-P and LTA in defining high platelet reactivity after STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: